Deutsch
English
Русский
  • Zertifizierungslogos der Hautklinik mit Links
  • Zertifizierungslogos der Hautklinik mit Links

Publikationen

Publikationen 2017

  • Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tüting T, Ulrich C, Wollina U, Hassel JC, Gutzmer R, Goerdt S, Zouboulis C, Leiter U, Eigentler TK, Garbe C. Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients. Brit J Dermatol (2017) in press
  • Gassenmaier M, Eigentler TK, Keim U, Goebeler M, Eckhard Fiedler E, Gerold Schuler G, Ulrike Leiter U, Weide B, Grischke EM, Martus P, Garbe C. Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry. J Invest Dermatol (2017) in press
  • Hosp C, Hamm H. Safety of available and emerging drug therapies for hyperhidrosis. Exp Opin Drug Safety (2017) in press
  • Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, Goebeler M, Cozzani E, Kern JS, Sitaru C, Lakoš Jukić I, Sárdy M, Uzun S, Jedlickova H, Gläser R, Kaneda M, Eming R, Göpel G, Ishii N, Greene B, Hashimoto T, Hertl M. Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita - a multicenter analysis. Brit J Dermatol (2017) in press
  • Borst A, Haferkamp S,  Grimm J, Rösch M, Zhu G, Guo S,  Li C, Gao T, Meierjohann S, Schrama D, Houben R. BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines.  Cancer Letters (2017) in press
  • Ugurel S, Loquai C, Terheyden P, Schadendorf D, Richtig E, Utikal J, Gutzmer R, Rass K, Sunderkötter C, Stein A, Fluck M, Kaatz M, Trefzer U, Kähler K, Stadler R, Berking C, Höller C, Kerschke L, Edler L, Kopp-Schneider A, Becker JC. Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial. Oncotarget (2017) in press
  • Thiem A, Kneitz H, Schummer P, Herz S, Schrama D, Houben R, Goebeler M, Schilling B, Gesierich A. Coincident metastatic melanoma and Merkel cell carcinoma with complete remission upon treatment with pembrolizumab. Acta Derm Venereol (2017) in press
  • Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak L, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R on behalf oft he EHSF Investigator Group. Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity. Br J Dermatol (2017) in press
  • Giner T, Benoit S, Kneitz H, Goebeler M. Sarkoidose – der dermatologische Blick auf eine seltene Multisystemerkrankung. Hautarzt, in press (2017)
  • Sticherling M, Franke A, Aberer E, Gläser R, Hertl M, Pfeiffer C, Rzany B, Schneider S, Shimanovich I, Werfel T, Wilczek A, Zillikens D, Schmidt A. An open, multicenter, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. Brit J Dermatol, in press (2017)
  • Sucker A, Zhao F, Pieper N, Heeke C, Maltaner R, Stadtler N, Real B, Bielefeld N, Howe S, Weide B, Gutzmer R, Utikal J, Loquai C, Gogas H, Klein-Hitpass L, Zeschnigk M, Westendorf AM, Trilling M, Horn S, Schilling B, Schadendorf D, Griewank KG, Paschen A. Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions. Nat Commun 8:15440 doi: 10.1038/ncomms15440 (2017)
  • Papapanagiotou M, Griewank KG, Hillen U, Schimming TT, Moeller LC, Führer D, Zimmer L, Roesch A, Sucker A, Schadendorf D, Livingstone E, Schilling B.  Trametinib-Induced Remission of an MEK1-Mutated Langerhans Cell Histiocytosis. JCO Precision Oncology, in press (2017)
  • Frings A, Frings V, Geerling G, Goebeler M, Schargus M. Progrediente Ulzeration der Periorbita. Ophthalmologe, in press, doi: 10.1007/s00347-017-0512-0 (2017)
  • Behle V, von Braunmühl T, Sayehli C, Gesierich A, Goebeler M, Geissinger E, Wobser M. Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis. Acta Derm Venereol, in press, doi: 10.2340/00015555-2700 (2017)
  • Trautmann A, Benoit S, Goebeler M, Stoevesandt J. “Treating Through” Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas. J Allergy Clin Immunol Pract (2017) in press
  • Improta G, Ritter C, Pettinato A, Vasta V, Schrama D, Fraggetta F, Becker JC. MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus in vivo. J Cancer Res Clin Oncol (2017) in press
  • Griewank KG, Müller H, Jackett LA, Emberger M, Möller I, van de Nes JA, Zimmer L, Livingstone E, Wiesner T, Scholz SL, Cosgarea I, Sucker A, Schimming T, Hillen U, Schilling B, Paschen A, Reis H, Mentzel T, Kutzner H, Rütten A, Murali R, Scolyer RA, Schadendorf D. SF3B1 and BAP1 mutations in blue nevus-like melanoma. Mod Pathol (2017) in press
  • Wobser M, Maurus K, Roth S, Appenzeller S, Weyandt G, Goebeler M, Rosenwald A, Geissinger E. MYD88 mutations in a distinct type of cutaneous marginal zone lymphoma with a non-class switched IgM-immunophenotype. Br J Dermatol (2017) in press
  • Haug V, Benoit S, Wohlleben M, Hamm H. Annular pustular psoriasis in a 14-month-old girl: a therapeutic challenge. J Dermatolog Treat (2017) in press
  • Frings VG, Böer-Auer A, Breuer K. Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis. Am J Dermatopathol (2017) in press
  • Ofner R, Ritter C, Ugurel S, Cerroni L, Stiller M, Bogenrieder T, Solca F, Schrama D, Becker JC. Non-reproducible sequence artifacts in FFPE tissue: an experience Report. J Cancer Res Clin Oncol  doi: 10.1007/s00432-017-2399-1 (2017) in press
  • Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, Göppner D, Schlaak M, Pföhler C, Utikal J, Heinzerling L, Cosgarea I, Engel J, Eckel R, Martens A, Mirlach L, Satzger I, Schubert-Fritschle G, Tietze JK, Berking C. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer 81, 36-44 (2017)
  • Scholz SL, Möller I, Reis H, Süßkind D, van de Nes JAP, Leonardelli S, Schilling B, Livingstone E, Schimming T, Paschen A, Sucker A, Murali R, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma. Invest Ophthalmol Vis Sci 58, 3464-3470 (2017)
  • M.B. Faries, J.F. Thompson, A.J. Cochran, R.H. Andtbacka, N. Mozzillo, J.S. Zager, T. Jahkola, T.L. Bowles, A. Testori, P.D. Beitsch, H.J. Hoekstra, M. Moncrieff, C. Ingvar, M.W.J.M. Wouters, M.S. Sabel, E.A. Levine, D. Agnese,
M. Henderson, R. Dummer, C.R. Rossi, R.I. Neves, S.D. Trocha, F. Wright, D.R. Byrd, M. Matter, E. Hsueh,
A. MacKenzie‐Ross, D.B. Johnson, P. Terheyden, A.C. Berger, T.L. Huston, J.D. Wayne, B.M. Smithers, H.B. Neuman, S. Schneebaum, J.E. Gershenwald, C.E. Ariyan, D.C. Desai, L. Jacobs, K.M. McMasters, A. Gesierich, P. Hersey, S.D. Bines, J.M. Kane, R.J. Barth, G. McKinnon, J.M. Farma, E. Schultz, S. Vidal‐Sicart, R.A. Hoefer, J.M. Lewis,
R. Scheri, M.C. Kelley, O.E. Nieweg, R.D. Noyes, D.S.B. Hoon, H.‐J. Wang, D.A. Elashoff, and R.M. Elashoff. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. New Engl J Med 376, 2211-2222 (2017)
  • Ritter C, Fan K, Paschen A, Reker Hardrup S, Ferrone S, Nghiem P, Ugurel S, Schrama D, Becker JC. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma. Sci Rep 7(1):2290. doi: 10.1038/s41598-017-02608-0 (2017)
  • Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A; ERIVANCE BCC Investigators. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer 17, 332. doi: 10.1186/s12885-017-3286-5 (2017)
  • Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M2 and the ALCANZA study group (Collaborators: Trotman J, Joske D, Prince HM, Taylor K, Lewis ID, Jonak C, Trautinger F, Bechter O, Wolter P, Bron D, de Lima VCC, Sanches JA Junior, Klasa R, Bagot M, Beylot-Barry M, Dalle S, D'Incan M, Dreno B, Grange F, Nicolay J, Stadler R, Weichenthal M, Wobser M, Assaf C, Loquai C, Quaglino P, Spina M, Zinzani PL, Bosi A, Fattori PP, Grzanka A, Walewski J, Lopez-Hernandez A, Ortiz-Romero PL, Roca JJR, Canales SN, Dummer R, Illidge T, Johnson R, Whittaker S, Morris S, McKay P, Scarisbrick J, Duvic M, Feldman T, Akilov O, Geskin L, Horwitz S, Kim YH, Pro B, Kuzel T, Lerner A, Eradat H, Sokol L, Fisher DC, Hughey S). Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet Jun 6. pii: S0140-6736(17)31266-7. doi: 10.1016/S0140-6736(17)31266-7 (2017)
  • Walter E, Vielmuth F, Rotkopf L, Sárdy M, Horváth ON, Goebeler M, Schmidt E, Eming R, Hertl M, Spindler V, Waschke J. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. Sci Rep 7(1):3579. doi: 10.1038/s41598-017-03697-7 (2017)
  • Dogliotti G, Kullmann L, Dhumale P, Thiele C, Panichkina O, Mendl G, Houben R, Haferkamp S, Püschel AW, Krahn MP. Membrane-binding and activation of LKB1 by phosphatidic acid is essential for development and tumour suppression. Nat Commun 8:15747 doi: 10.1038/ncomms15747 (2017)
  • Baur J, Mathe K, Gesierich A, Weyandt G, Wiegering A, Germer CT, Gasser M, Pelz JOW. Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients. World J Surg Oncol 15:99 (2017)
  • Trautmann A, Stoevesandt J. Reply. J Allergy Clin Immunol Pract 5, 535-536 (2017)
  • Mergler R, Kerstan A, Schmidt E, Goebeler M, Benoit S. Atypical clinical and serological manifestation of pemphigus vegetans: a case report and review of the literature. Case Rep Dermatol 9, 121–130 (2017)
  • Frings VG, Roth S, Riedmiller AL, Schäfer K, Goebeler M, Rosenwald A, Geissinger E, Wobser M. Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20. Acta Derm Venereol 97, 534-536 (2017) 
  • Griewank KG, Schilling B. Next-Generation Sequencing to Guide Treatment of Advanced Melanoma. Am J Clin Dermatol 18, 303-310 (2017)
  • Reichel A, Hamm H, Wiegering V, Wiewrodt B, Neubauer H, Ernestus K, Winkler B. Kaposiformes Hämangioendotheliom mit Kasabach-Merritt-Syndrom: erfolgreiche Therapie mit Sirolimus. J Dtsch Dermatol Ges 15, 329-331 (2017)
  • Hamm H. Krätzealarm im Altenheim. MMW Fortschr Med 159, 22 (2017)
  • Toksoy A, Sennefelder H, Adam C, Hofmann S, Trautmann A, Goebeler M, Schmidt M. Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir. J Biol Chem 292, 2805-2814 (2017)
  • Schäfer K, Bauer B, Donhauser J, Kerstan A, Hamm H. Becker Naevus Syndrome of the Lower Body: One Case and Review of the Literature. Acta Derm Venereol 97, 499-504 (2017)
  • Gutzmer R, Koop A, Meier F, Hassel JC, Terheyden P, Zimmer L, Heinzerling L, Ugurel S, Pföhler C, Gesierich A, Livingstone E, Satzger I, Kähler KC; German Dermatooncology Group (DeCOG). Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity. Eur J Cancer 75, 24-32 (2017)
  • Schrama D, Ritter C, Becker JC. T cell receptor repertoire usage in cancer as a surrogate marker for immune Responses. Semin Immunopathol 39, 255-268 (2017)
  • Ofner R, Ritter C, Heidenreich B, Kumar R, Ugurel S, Schrama D, Becker JC. Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients. J Cancer Res Clin Oncol 143, 613-617 (2017)
  • Frings VG, Trautmann A, Goebeler M, Wobser M. Dermpath & Clinic: Multiple reactive eccrine syringofibroadenomas. Eur J Dermatol 27, 102-104 (2017)
  • Toksoy A, Strifler S, Benoit S, Grigoleit GU, Knop S, Mielke S, Buder-Bakhaya K, Roth S, Goebeler M, Rosenwald A, Geissinger E, Wobser M. Facial Swelling and Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr Virus-associated T-cell Lymphoproliferation with Subsequent Development of Lymphoma. Acta Derm Venereol 97, 379-380 (2017)
  • Sadik CD, Pas HH, Bohlmann MK, Mousavi S, Benoit S, Sárdy M, Terra JB, Lima AL, Hammers CM, van Beek N, Bangert C, Zillikens D, Schmidt E. Value of BIOCHIP Technology in the Serological Diagnosis of Pemphigoid Gestationis. Acta Derm Venereol 97, 128-130 (2017)
  • Adam C, Wohlfarth J, Haußmann M, Sennefelder H, Rodin A, Maler M, Martin SF, Goebeler M, Schmidt M. Allergy-inducing chromium compounds trigger potent innate immune stimulation via ROS-dependent inflammasome activation. J Invest Dermatol 137, 367-376 (2017)

Publikationen 2016

  • Almanzar G, Klein M, Schmalzing M, Hilligardt D, El Hajj N, Kneitz H, Wild V, Rosenwald A, Benoit S, Hamm H, Tony HP, Haaf T, Goebeler M, Prelog M. Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis. Int Arch Allergy Immunol 171, 141-154 (2016)
  • Sunderkötter C, Feldmeier H, Fölster-Holst R, Geisel B, Klinke-Rehbein S, Nast A, Philipp S, Sachs B, Stingl J, Stoevesandt J, Hamm H. S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung. J Dtsch Dermatol Ges 14, 1160-1171 (2016)
  • Müller-Richter UD, Weyandt GH, Woeckel A, Kübler AC. Vermilion Reconstruction with Genital Mucosa. Plast Reconstr Surg Glob Open 4(5):e701 (2016)
    Lange J, Weil F, Riegler C, Groeber F, Rebhan S, Kurdyn S, Alb M, Kneitz H, Gelbrich G, Walles H, Mielke S. Interactions of donor sources and media influence the histomorphological quality of full-thickness skin models. Biotechnol J 11, 1352-1361 (2016)
  • Basmanav FB, Cau L, Tafazzoli A, Méchin MC, Wolf S, Romano MT, Valentin F, Wiegmann H, Huchenq A, Kandil R, Garcia Bartels N, Kilic A, George S, Ralser DJ, Bergner S, Ferguson DJ, Oprisoreanu AM, Wehner M, Thiele H, Altmüller J, Nürnberg P, Swan D, Houniet D, Büchner A, Weibel L, Wagner N, Grimalt R, Bygum A, Serre G, Blume-Peytavi U, Sprecher E, Schoch S, Oji V, Hamm H, Farrant P, Simon M, Betz RC. Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome. Am J Hum Genet 99, 1292-1304 (2016)
  • Nicolay JP, Wobser M. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy. J Dtsch Dermatol Ges 14, 1207-1224 (2016)
  • Bluemel C, Safak G, Cramer A, Wöckel A, Gesierich A, Hartmann E, Schmid JS, Kaiser F, Buck AK, Herrmann K. Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes.  Eur J Nucl Med Mol Imaging 43, 2304-2312 (2016)
  • Behle V, Goebeler M, Gesierich A. Seriously saRComa: Neurofibrosarcoma. Eur J Dermatol 26, 517-518 (2016)
  • Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E. Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Oncol Ther 4, 199-210 (2016)
  • Thiem A, Kütt S, Hamm H. 'Television alopecia': a rare cause of pressure alopecia. J Eur Acad Dermatol Venereol 30, 504-505 (2016)
  • Trautmann A, Anders D, Stoevesandt J. H1-Antihistamine Premedication in NSAID-Associated Urticaria. J Allergy Clin Immunol Pract 4, 1205-1212 (2016)
  • Dieckmann R, Boone I, Brockmann SO, Hammerl JA, Kolb-Mäurer A, Goebeler M, Luch A, Dahouk SA. Risiken für bakterielle Infektionen nach Tätowierungen. Ein systematisches Literaturreview. Dtsch Arztebl Int 113, 665-71 (2016)
  • Klein M, Schmalzing M, Almanzar G, Benoit S, Hamm H, Tony HP, Goebeler M, Prelog M. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc). Autoimmunity 25, 1-15 (2016)
  • Ellerbroek V, Hamm H. Pityriasis Lichenoides et Varioliformis Acuta: Remission with Hypopigmentation. J Pediatr 176, 211-211 (2016)
  • Ziegler W, Lempert S, Goebeler M, Kolb-Mäurer A. Tinea capitis: Erregerspektrum und Epidemiologie im zeitlichen Wandel. J Dtsch Dermatol Ges 14, 818-26 (2016)
  • Karademir F, Rose C, Goebeler M, Kneitz H, Hamm H, Wobser M. Multiple eruptive Angiofibrome bei einem 14-jährigen Mädchen. J Dtsch Dermatol Ges 14, 746-748 (2016)
  • Ochsendorf F, Bandholz T, Emmert S, Hartmann K, Hartmann M, Hornung T, Jünger M, Kollewe T, Löser C, Moll I, Psotta-Schachtner C, Spornraft-Ragaller P, Ständer S, von Stebut-Borschitz E, Hamm H. 111 Top-Lernziele Dermatologie: Lernzielkatalog für Haut- und Geschlechtskrankheiten der Deutschen Dermatologischen Gesellschaft. J Dtsch Dermatol Ges 14, 637-43 (2016)
  • Hamm H. Severely impaired quality of life. "My sweating is intolerable.". MMW Fortschr Med 158, 46-50 (2016)
  • Stolze I, Trautmann A, Goebeler M, Stoevesandt J: Dangerous Leg Cramps: Severe Pustular Exanthema Caused by an Over-the-Counter Drug. Acta Derm Venereol 96, 703-704 (2016)
  • Behle V, Wobser M, Goebeler M, Stoevesandt J: Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod. Mult Scler 22, 969-71 (2016)
  • Zhu G, Yi X, Haferkamp S, Hesbacher S, Li C, Goebeler M, Gao T, Houben R, Schrama D: Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells. Cancer Lett 376, 43-52 (2016)
  • Ritter C, Fan K, Paulson KG, Nghiem P, Schrama D, Becker JC: Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Sci Rep 6, 21678 (2016)
  • Willmes C, Kumar R, Becker JC, Fried I, Rachakonda PS, Poppe LM, Hesbacher S, Schadendorf D, Sucker A, Schrama D, Ugurel S: SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma. Oncotarget 7, 10117-32 (2016)
  • Alrefai H, Muhammad K, Rudolf R, Pham DA, Klein-Hessling S, Patra AK, Avots A, Bukur V, Sahin U, Tenzer S, Goebeler M, Kerstan A, Serfling E. NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells. Nat Commun 7, 11724 (2016)
  • Lengfeld J, Buder-Bakhaya K, Goebeler M, Wobser M. Bisphosphonate-Mediated Oral Ulcers: A Rare Differential Diagnosis of Erosive Oral Lesions. Dermatology 232, 117-121 (2016)
  • Schrama D, Hesbacher S, Angermeyer S, Schlosser A, Haferkamp S, Aue A, Adam C, Weber A, Schmidt M, Houben R. Serine 220 phosphorylation of the Merkel cell polyomavirus Large T antigen crucially supports growth of Merkel cell carcinoma cells. Int J Cancer 138, 1153-62 (2016)
  • Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174, 514-521 (2016)
  • Thomas AC, Zeng Z, Rivière JB, O'Shaughnessy R, Al-Olabi L, St-Onge J, Atherton DJ, Aubert H, Bagazgoitia L, Barbarot S, Bourrat E, Chiaverini C, Chong WK, Duffourd Y, Glover M, Groesser L, Hadj-Rabia S, Hamm H, Happle R, Mushtaq I, Lacour JP, Waelchli R, Wobser M, Vabres P, Patton EE, Kinsler VA: Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. J Invest Dermatol 136, 770-8 (2016)
  • Hesbacher S, Pfitzer L, Wiedorfer K, Angermeyer S, Borst A, Haferkamp S, Scholz CJ, Wobser M,  Schrama D, Houben R: RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells. Oncotarget (2016, in press)
  • Trautmann A, Seidl C, Stoevesandt J, Seitz CS: General anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy 46, 125-32 (2016)
  • Schmidt M, Goebeler M, Martin SF: Methods to Investigate the Role of Toll-Like Receptors in Allergic Contact Dermatitis. Methods Mol Biol 1390:319-40 (2016)
  • Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N; German Network for Systemic Scleroderma. Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients. J Rheumatol 43:66-74 (2016)
  • Thiem A, Mergler R, Kneitz H, Weyandt G, Goebeler M, Gesierich A: Acne inversa-like skin lesions as a potential adverse event during vemurafenib therapy. J Dtsch Dermatol Ges 14, 427-8 (2016)
  • Hosp C, Naumann MK, Hamm H: Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea. Semin Neurol 36, 20-8 (2016)
  • Wiedemann K, Schmid C, Hamm H, Wirbelauer J: Staphylococcal Scalded Skin Syndrome in a Very Low Birth Weight Premature Infant. Z Geburtshilfe Neonatol 220, 25-8 (2016)
  • Hamm H: Kinderdermatologie: ein Kleinod unseres Fachgebiets. J Dtsch Dermatol Ges 14, 345-6 (2016)
  • Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, Gutzmer R, Utikal JS,  Göppner D, Hassel JC, Meier F, Tietze JK, Forschner A, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentlicher T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G, Dummer R, Heinzerling LM. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 60, 210-25 (2016)
  • Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, Hassel JC, Meier F, Tietze JK, Thomas J, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentler T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G,  Dummer R, Heinzerling LM. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. Eur J Cancer 60, 190-209 (2016)

Publikationen 2015

  • Bauer B, Trautmann A. Swollen Ears and Nose Bleeding Accompanied by Skin Papules. Pediatr Dermatol 32, 863-4 (2015)
  • Behle V, Kneitz H, Goebeler M. Residents' corner October 2015. Seriously saRComa!: Atypical fibroxanthoma. Eur J Dermatol 25, 520-1 (2015)
  • Brenner I, Roth S, Flossbach L, Wobser M, Rosenwald A, Geissinger E. Lack of MYD88 L265P Mutation in Primary Cutaneous Marginal Zone Lymphoma. Brit J Dermatol 173, 1527-1528 (2015)
  • Moonen JR, Lee ES, Schmidt M, Maleszewska M, Koerts JA, Brouwer LA, van Kooten TG, van Luyn MJ, Zeebregts CJ, Krenning G, Harmsen MC. Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress. Cardiovasc Res 108, 377-86 (2015)
  • Florence ME, Massuda JY, Soares TC, Stelini RF, Poppe LM, Bröcker EB, Metze K, Cintra ML, de Souza EM. p53 immunoexpression in stepwise progression of cutaneous squamous cell carcinoma and correlation with angiogenesis and cellular proliferation. Pathol Res Pract 211, 782-8 (2015)
  • Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators (Kollaboratoren: u. a. Benoit S).  Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 386, 541-51 (2015)
  • Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, Foster KA, Whitham D, Williams HC; BLISTER study group (Kollaboratoren: u. a. Benoit S). A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. Br J Dermatol 173, 227-34 (2015)
  • Recke A, Vidarsson G, Ludwig RJ, Freitag M, Möller S, Vonthein R, Schellenberger J, Haase O, Görg S, Nebel A, Flachsbart F, Schreiber S, Lieb W, Gläser R, Benoit S, Sárdy M, Eming R, Hertl M, Zillikens D, König IR, Schmidt E, Ibrahim S; German AIBD Genetic Study Group. Collaborators (18) Benoit S, Däschlein G, Eming R, Gläser R, Goebeler M, Goetze S, Günther C, Hadaschik E, Homey B, Hunzelmann N, Kreuter A, Kunz M, Lippert U, Ludwig-Peitsch W, Pföhler C, Sárdy M, Sticherling M, Worm M.  Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases. J Autoimmun 61, 36-44  (2015)
  • Sommer M, Trautmann A, Stoevesandt J. Relief of photoallergy: atorvastatin replacing simvastatin. J Investig Allergol Clin Immunol 25, 138-40 (2015)
  • Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM).  Allergo J Int 24, 94-105 (2015)
  • Stoevesandt J, Hosp C, Kerstan A, Trautmann A. Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective. Ann Allergy Asthma Immunol 114, 411-6 (2015)
  • Odongo L, Mulyowa G, Goebeler M, Trautmann A. Bet v 1- and Bet v 2-Associated Plant Food Sensitization in Uganda and Germany: Differences and Similarities. Int Arch Allergy Immunol 167, 264-269 (2015)
  • Kneitz H, Wobser M, Stoevesandt J, Goebeler M. Therapieresistente purulente Papeln und Knoten gluteal und im Bereich beider Oberschenkel. Hautarzt 66, 636-8 (2015)
  • Lengfeld J, Kneitz H, Goebeler M, Kolb-Mäurer A. Panniculitis due to pancreatic disease. JDDG 13, 807-9 (2015)
  • Hirose M, Schilf P, Benoit S, Eming R, Gläser R, Homey B, Kunz M, Nebel A, Peitsch WK, Pföhler C, Sárdy M, Schreiber S, Zillikens D, Schmidt E, Ibrahim SM; German AIBD Genetic Study Group. Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population. Exp Dermatol 24, 715-7 (2015)
  • Huth S, Heise R, Vetter-Kauczok CS, Skazik C, Marquardt Y, Czaja K, Knüchel R, Merk HF, Dahl E, Baron JM. Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models. Exp Dermatol 24, 663-8 (2015)
  • Mössner R, Zimmer L, Berking C, Hoeller C, Loquai C, Richtig E, Kähler KC, Hassel JC, Gutzmer R, Ugurel S. Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature. J Eur Acad Dermatol Venereol 29,1797-806 (2015)
  • Erfle H, Pashayeva K, Harder N, Zhang L, Rohr K, Schadendorf D, Ugurel S, Keese M. Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypes. Biotechnol J 10, 1467-77 (2015)
  • Kneitz H, Mentzel T, Wobser M, Goebeler M. Kutanes PECom des rechten Unterschenkels. JDDG 13, 815-7 (2015)
  • Kolb-Mäurer A, Goebeler M, Mäurer M. Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis. Int J Mol Sci 16, 14951-60 (2015)
  • Schmidt M, Goebeler M. Immunology of metal allergies. JDDG 13, 653-9 (2015)
  • Bauer B, Goebeler M, Weissbrich B, Kerstan A. Kerinokeratosis Papulosa of Childhood. Dermatology 231, 1-4 (2015)
  • Teichert M, Stumpf C, Booken N, Wobser M, Nashan D, Hallermann C, Mogler C, Müller CS, Becker JC, Moritz RK, Andrulis M, Nicolay JP, Goerdt S, Thomas M, Klemke CD, Augustin HG, Felcht M. Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis. Exp Dermatol 24, 424-9(2015)
  • Schmieder A, Poppe M, Hametner C, Meyer-Schraml H, Schaarschmidt ML, Findeisen P, Benoit S, Bauer B, Schmid S, Goebeler M, Goerdt S, Ludwig-Peitsch WK. Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study. Arch Dermatol Res 307, 413-24 (2015)
  • Wobser M, Roth S, Reinartz T, Rosenwald A, Goebeler M, Geissinger E. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas. Br J Dermatol 172, 1573-80 (2015)
  • Vaman V S A, Poppe H, Houben R, Grunewald TG, Goebeler M, Butt E. LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression. PLoS One 10, e0129219 (2015)
  • Behle V, Goebeler M. Residents'corner April 2015. Seriously saRComa! : Dermatofibrosarcoma protuberans. Eur J Dermatol 25, 214 (2015)
  • Benoit S, Hamm H. Differenzialdiagnose erosiver und ulzeröser Mundschleimhauterkrankungen im Kindesalter. Hautarzt 66, 258-66 (2015)
  • Höger PH, Hamm H. Psoriasis vulgaris bei Kindern und Jugendlichen. Hautarzt 66, 267-76 (2015)
  • Hamm H, Höger PH. Nachwuchsprobleme. Hautarzt 66, 234-35 (2015)
  • Wobser M, Ernestus K, Hamm H. Pediatric dermatohistopathology - histopathology of skin diseases in newborns and infants. J Dtsch Dermatol Ges 13, 535-48 (2015)
  • Kneitz H, Motschenbacher S, Wobser M, Goebeler M. Photoletter to the editor: Giant cutaneous horn associated with squamous cell carcinoma. J Dermatol Case Rep 9, 27-8 (2015)
  • Poppe H, Kerstan A, Böckers M, Goebeler M, Geissinger E, Rosenwald A, Hamm H. Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype. J Cutan Pathol 42, 258-64 (2015)
  • Leikam C, Hufnagel AL, Otto C, Murphy DJ, Mühling B, Kneitz S, Nanda I, Schmid M, Wagner TU, Haferkamp S, Bröcker EB, Schartl M, Meierjohann S. In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells. Cell Death Dis 6, e1711 (2015)
  • Benoit S, Goebeler M. Mepacrine in Recalcitrant Cutaneous Lupus Erythematosus: Old-fashioned or Still Useful? Acta Derm Venereol 95, 596-9 (2015)
  • Zeller S, Lempert S, Goebeler M, Hamm H, Kolb-Mäurer A. Cladosporium cladosporioides: a so far unidentified cause of white piedra. Mycoses 58, 315-7 (2015)
  • Hill R, Kalathur RK, Colaço L, Brandão R, Ugurel S, Futschik M, Link W. TRIB2 as a biomarker for diagnosis and progression of melanoma. Carcinogenesis 36, 469-77 (2015)
  • Ugurel S, Loquai C, Kähler K, Hassel J, Berking C, Zimmer L, Haubitz I, Satzger I, Müller-Brenne T, Mikhaimer NC, Becker JC, Kilian KJ, Schadendorf D, Heinzerling L, Kaatz M, Utikal J, Göppner D, Pföhler C, Pflugfelder A, Mössner R, Gutzmer R; Dermatologic Cooperative Oncology Group (DeCOG). A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival. Ann Oncol 26, 573-82 (2015)
  • Komaravolu RK, Adam C, Moonen JR, Harmsen MC, Goebeler M, Schmidt M. Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1. Cardiovasc Res 105, 86-95 (2015)
  • Wobser M, Bauer B, Goebeler M. Subcutaneous nodule on the scrotum. J Dtsch Dermatol Ges 13, 165-7 (2015)
  • Houben R, Angermeyer S, Haferkamp S, Aue A, Goebeler M, Schrama D, Hesbacher S. Characterization of functional domains in the Merkel cell polyoma virus Large T antigen. Int J Cancer 136, E290-300 (2015)
  • Thode C, Woetmann A, Wandall HH, Carlsson MC, Qvortrup K, Kauczok CS, Wobser M, Printzlau A, Odum N, Dabelsteen S. Malignant T Cells Secrete Galectins and Induce Epidermal Hyperproliferation and Disorganized Stratification in a Skin Model of Cutaneous T Cell Lymphoma. J Invest Dermatol 135, 238-246 (2015)
  • Zörnig I, Halama N, Lorenzo Bermejo J, Ziegelmeier C, Dickes E, Migdoll A, Kaiser I, Waterboer T, Pawlita M, Grabe N, Ugurel S, Schadendorf D, Falk C, Eichmüller SB, Jäger D. Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients. Int J Cancer 136, 138-5 (2015)

Publikationen 2014

  • Starke J, Wehrle-Haller B, Friedl P: Plasticity of the actin cytoskeleton in response to extracellular matrix nanostructure and dimensionality. Biochem Soc Trans. 42, 1356-66 (2014)
  • Brasch J, Becker D, Aberer W, Bircher A, Kränke B, Jung K, Przybilla B, Biedermann T, Werfel T, John SM, Elsner P, Diepgen T, Trautmann A, Merk HF, Fuchs T, Schnuch A. Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG. Allergo J Int 23, 126-138 (2014)
  • Wobser M, Hamm H. Teleangiectasia macularis eruptiva perstans with congenital onset in a 5-year-old girl. Clin Dermatol 2, 144-146 (2014)
  • Schrama D, Ugurel S, Sucker A, Ritter C, Zapatka M, Schadendorf D, Becker JC. STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients. Front Med (Lausanne) 1, 47 (2014)
  • Chandran PA, Keller A, Weinmann L, Seida AA, Braun M, Andreev K, Fischer B, Horn E, Schwinn S, Junker M, Houben R, Dombrowski Y, Dietl J, Finotto S, Wölfl M, Meister G, Wischhusen J. The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells. J Leukoc Biol 96, 633-45 (2014)
  • Behr DS, Peitsch WK, Hametner C, Lasitschka F, Houben R, Schönhaar K, Michel J, Dollt C, Goebeler M, Marx A, Goerdt S, Schmieder A. Prognostic value of immune cell infiltration, tertiary lymphoid structures and pd-l1 expression in Merkel cell carcinomas. Int J Clin Exp Pathol 7, 7610-21 (2014)
  • Fredholm S, Gjerdrum LM, Willerslev-Olsen A, Petersen DL, Nielsen IØ, Kauczok CS, Wobser M, Ralfkiaer U, Bonefeld CM, Wasik MA, Krejsgaard T, Geisler C, Ralfkiaer E, Gniadecki R, Woetmann A, Odum N. STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides. Anticancer Res 34, 5277-86 (2014)
  • Behle V, Hamm H. Developmental abnormalities and nevi of the scalp. Hautarzt 65, 1022-9 (2014)
  • Hamm H, Wolff H. Blickpunkt Kopfhaut. Hautarzt 65, 1020-1 (2014)
  • Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT, Seo A, Koelle DM, Madeleine MM, Bhatia S, Nakajima H, Sano S, Hardwick J, Disis ML, Cleary MA, Becker JC, Nghiem P. Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma. Cancer Immunol Res 2, 1071-9 (2014)
  • Buder K, Hamm H. Residents' corner October 2014. Nail it! A bleeding tumour at the fingertip. Eur J Dermatol 24, 637-8 (2014)
  • Schrama D, Groesser L, Ugurel S, Hafner C, Pastrana DV, Buck CB, Cerroni L, Theiler A, Becker JC. Presence of Human Polyomavirus 6 in Mutation-Specific BRAF Inhibitor-Induced Epithelial Proliferations. JAMA Dermatol 150, 1180-6 (2014)
  • Havlickova B, Weyandt GH. Therapeutic management of anal eczema: an evidence-based review. Int J Clin Pract 68, 1388-99 (2014)
  • Humbert P, Faivre B, Véran Y, Debure C, Truchetet F, Bécherel PA, Plantin P, Kerihuel JC, Eming SA, Dissemond J, Weyandt G, Kaspar D, Smola H, Zöllner P; the CLEANSITE study group. Protease-modulating polyacrylate-based hydrogel stimulates wound bed preparation in venous leg ulcers - a randomized controlled trial. J Eur Acad Dermatol Venereol 28, 1742-50 (2014)
  • Trautmann A, Seitz CS, Stoevesandt J, Kerstan A. Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited. Clin Exp Allergy 44, 1531-8 (2014)
  • Karl I, Jossberger-Werner M, Schmidt N, Horn S, Goebeler M, Leverkus M, Wajant H, Giner T. TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis. Cell Death Dis 5, e1444 (2014)
  • Benoit S, Schlipf N, Hausser I, Fischer J, Hamm H. White Sponge Nevus - A Rare Autosomal Dominant Keratinopathy. Klin Padiatr 226, 375-376 (2014)
  • Hamm, H. Impact of Hyperhidrosis on Quality of Life and its Assessment. Dermatol Clin 32, 467-76 (2014)
  • Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S, Bonsmann G; The EUSCLE Co-Authors (u. a. Benoit S, Bröcker E). Influence of Smoking on Disease Severity and Antimalarial Therapy in Cutaneous Lupus Erythematosus: Analysis of 1002 Patients from the EUSCLE Database. Br J Dermatol 171, 571-9 (2014)
  • Kolb-Mäurer A, Betz RC, Hamm H. Odd-Looking Hair and Progressive Alopecia in Mother and Son. JAMA Dermatol 150, 567-8 (2014)
  • Aigner B, Ugurel S, Kaddu S, Becker JC. Kutane Sarkome. Update ausgewählter Entitäten fibrohistiozytärer und myofibrozytärer Morphologie. Hautarzt 65, 614-622 (2014)
  • Gutzmer R, Hassel JC, Kähler KC, Loquai C, Mössner R, Ugurel S, Zimmer L, für das Komitee "Kutane Nebenwirkungen" der ADO. Kutane Nebenwirkungen der medikamentösen Tumortherapie mit BRAF- und MEK-Inhibitoren. Hautarzt 65, 582-89 (2014)
  • Leufke C, Leykauf J, Krunic D, Jauch A, Holtgreve-Grez, Böhm-Steuer B, Bröcker E-B, Mauch C, Utikal J, Hartschuh W, Purdie KJ, Boukamp P. The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. Oncogene 33, 3506-18 (2014)
  • Gerstner S, Kneitz H, Bröcker EB, Trautmann A. Differentialdiagnose Angioödem. Akut ödematöses Skleromyxödem. Hautarzt 65, 454-7(2014)
  • Wieshuber C, Stoevesandt J, Trautmann A. The needle in the haystack: allergic anaphylaxis caused by the local anesthetic articaine. Eur Ann Allergy Clin Immunol 46, 38-40 (2014)
  • Seitz CS, Brockow K, Hain J, Trautmann A. Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase? Allergy Asthma Clin Immunol 10, 19 (2014)
  • Buder K, Lapa C, Kreissl MC, Schirbel A, Herrmann K, Schnack A, Bröcker EB, Goebeler M, Buck AK, Becker JC. Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging. BMC Cancer 14, 268 (2014)
  • Buder K, Hamm H. Residents' corner April 2014. Nail it!: eye-catching nail folds. Eur J Dermatol 24, 283-4 (2014)
  • Angermeyer S, Hesbacher S, Becker JC, Schrama D, Houben R. Response to Shuda et al. J Invest Dermatol 134, 1481-2 (2014)
  • Höger PH, Hamm H. Psoriasis vulgaris bei Kinder und Jugendlichen. Monatsschr Kinderheilkd 162, 163-77 (2014)
  • Stoevesandt J, Hain J, Stolze I, Kerstan A, Trautmann A. Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy buildup phase. Clin Exp Allergy 44, 747-55 (2014)
  • Adam C, Baeurle A, Brodsky JL, Wipf P, Schrama D, Becker JC, Houben R. The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma. PLoS ONE 9, e92041 (2014)
  • Karademir F, Kerstan A, Hamm H. Anetodermisches Pilomatrikom. Seltene Variante eines häufigen Adnextumors im Kindesalter. Hautarzt 65, 59-62 (2014)
  • Benoit S, Goebeler M. Vasculitis in childhood - a dermatological approach. J Dtsch Dermatol Ges 12, 124-9 (2014)
  • Stoevesandt J, Hosp C, Kerstan A, Trautmann A. Risikostratifizierung systemischer allergischer Reaktionen während Einleitung der spezifischen Immuntherapie mit Bienen- und Wespengift. J Dtsch Dermatol Ges 12, 244-56 (2014)
  • Buder K, Ruppert S, Trautmann A, Bröcker E-B, Goebeler M, Kerstan A. Angiolymphoide Hyperplasie mit Eosinophilie und Morbus Kimura - ein klinischer und histopathologischer Vergleich. J Dtsch Dermatol Ges 12, 224-8 (2014)
  • Ugurel S, Mentzel T, Utikal J, Helmbold P, Mohr P, Pföhler C, Schiller M, Hauschild A, Hein R, Kämpgen E, Kellner I, Leverkus M, Becker JC, Ströbel P, Schadendorf D. Neo-adjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase-II DeCOG trial with long-term follow-up. Clin Cancer Res 20, 499-510 (2014)
  • Weishaupt J, Kolb-Mäurer A, Lempert S, Nenoff P, Uhrlaß S, Hamm H, Goebeler M. A different kind of hedgehog pathway: tinea manus due to Trichophyton erinacei transmitted by an African pygmy hedgehog (Atelerix albiventris). Mycoses 57, 125-7 (2014)
  • Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM, Place CS, Taylor-Weiner A, Whittaker S, Kryukov GV, Hodis E, Rosenberg M, McKenna A, Cibulskis K, Farlow D, Zimmer L, Hillen U, Gutzmer R, Goldinger SM, Ugurel S, Gogas HJ, Egberts F, Berking C, Trefzer U, Loquai C, Weide B, Hassel JC, Gabriel SB, Carter SL, Getz G, Garraway LA, Schadendorf D; Dermatologic Cooperative Oncology Group of Germany (DeCOG). The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma. Cancer Discov 4, 94-109 (2014)
  • Heiduschka G, Lill C, Seemann R, Brunner M, Schmid R, Houben R, Bigenzahn J, Thurnher D. The effect of resveratrol in combination with irradiation and chemotherapy. Strahlenther Onkol 190, 75-80 (2014)
  • Waldenburger S, Vogel U, Goebeler M, Kolb-Mäurer A. Ambulant erworbene Hautinfektionen durch Staphylococcus aureus: spielt das Toxin Panton-Valentine-Leukozidin eine Rolle? J Dtsch Dermatol Ges 12, 59-67 (2014)
  • Goldinger SM, Zimmer L, Schulz C, Ugurel S, Hoeller C, Kaehler KC, Schadendorf D, Hassel JC, Becker J, Hauschild A, Dummer R; Dermatology Cooperative Oncology Group (DeCOG). Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients. Eur J Cancer 50, 406-10 (2014)
  • Buder K, Müller PA, Beckmann G, Ugurel S, Bröcker EB, Becker JC. Denileukin Diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell lymphoma (Mycosis fungoides): report of four cases. Acta Derm Venereol 94, 94-96(2014)
  • Houben R, Schmid CP, Maier M, Wobser M, Motschenbacher S, Becker JC, Vetter-Kauczok CS, Weyandt G, Hesbacher S, Haferkamp S. p53 Regulation by TRP2 Is Not Pervasive in Melanoma. PLoS ONE 9, e87440 (2014)

Publikationen 2013

  • Sigges J, Biazar C, Landmann A, Ruland V, Patsinakidis N, Amler S, Bonsmann G, Kuhn A; EUSCLE Co-Authors (u. a. Benoit S, Bröcker E). Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus. Autoimmun Rev 12, 694-702 (2013)
  • Buder K, Gesierich A, Gelbrich G, Goebeler M. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med 2, 674-86 (2013)
  • Wobser M, Petrella T, Kneitz H, Kerstan A, Goebeler M, Rosenwald A, Geissinger E. Extrafacial indolent CD8-positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet. J Cutan Pathol 40, 955-61 2013)
  • Wobser M, Kerstan A, Kneitz H, Goebeler M, Kunzmann V, Rosenwald A, Geissinger E. Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobin A deficiency. J Cutan Pathol 40, 1035-41 (2013)
  • Poppe H, Hamm H. Piezogenic papules in Ehlers-Danlos syndrome.  J Pediatr 163, 1788 (2013)
  • Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E. Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol 26, 1568-76 (2013)
  • Wobser M, Haferkamp S, Roth S, Meyer-ter-Vehn T, Pfister A, Giner T, Rütten A, Kneitz H, Goebeler M, Geissinger E. Periocular cutaneous oncocytoma with signs of disrupted oxygen metabolism. J Cutan Pathol 40 1054-8(2013)
  • Kolb-Mäurer A, Kneitz H, Goebeler M. Bortezomib-induziertes Sweet-ähnliches Syndrom. J Dtsch Dermatol Ges 11, 1200-2 (2013)     
  • Stoevesandt J, Hofmann B, Hain J, Kerstan A, Trautmann A. Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom. Allergy Asthma Clin Immunol 9, 33 (2013)
  • Benoit S, Hamm H. Psoriasis from a Prosthesis: unusual Koebner Phenomenon in a girl with autoamputation of the leg. Pediatr Dermatol 30, e106-7 (2013)
  • Poppe LM, Müller PA, Poppe H, Bröcker EM, Ugurel S, Weyandt GH. Chronic perianal ulceration as the initial symptom of Langerhans cell histiocytosis in adults. Eur J Dermatol 23, 551-52 (2013)
  • Panayotova-Dimitrova D, Feoktistova M, Ploesser M, Kellert B, Hupe M, Horn S, Makarov R, Jensen F, Porubsky S, Schmieder A, Zenclussen AC, Marx A, Kerstan A, Geserick P, He You-Wen, Leverkus M. cFLIP Regulates Skin Homeostasis and Protects against TNF-Induced Keratinocyte Apoptosis. Cell Reports 5, 397-408 (2013)
  • Poppe H, Poppe L, Goebeler M, Trautmann A. Treatment of disseminated granuloma annulare with oral vitamin E: “primum nil nocere”. Dermatology 227, 83-8 (2013)
  • Wobser M, Siedel C, Kneitz H, Bröcker EB, Goebeler M, Houben R, Geissinger E. Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma. Acta Derm Venereol 93, 656-62 (2013)
  • Buder K, Kolb-Mäurer A. Nail it! Sudden nail loss. Eur J Dermatol 23, 294 (2013)
  • Müller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, Rzany B. Efficacy and safety of methantheline bromide (Vagantin(®)) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol 27, 1278-84 (2013)
  • Degen A, Weichenthal M, Ugurel S, Trefzer U, Kilian K, Garbe C, Egberts F, Poppe LM, Hauschild A, Gutzmer R. Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial). J Dtsch Dermatol Ges 11, 846-53 (2013)
  • Buder K, Poppe LM, Bröcker EB, Goebeler M, Rosenwald A, Geissinger E, Kerstan A. Primary cutaneous follicular helper T-cell lymphoma: diagnostic pitfalls of this new lymphoma subtype. J Cutan Pathol 40, 903-8 (2013)
  • Seitz CS, Rose C, Kerstan A, Trautmann A. Drug-induced exanthems: Correlation of allergy testing with histologic diagnosis. J Am Acad Dermatol 69, 721-8 (2013)
  • Stoevesandt J, Hamm H. Transverse nasal novelties: a critical re-evaluation of the "allergic salute". Eur J Dermatol 23, 526-7 (2013)
  • Steinke SIB, Peitsch WK, Ludwig A, Goebeler M. Cost-of-illness in psoriasis: Comparing inpatient and outpatient therapy. PLoS ONE 8, e78152 (2013)
  • Starke J, Maaser K, Wehrle-Haller B, Friedl P. Mechanotransduction of mesenchymal melanoma cell invasion into 3D collagen lattices: Filopod-mediated extension-relaxation cycles and force anisotropy. Exp Cell Res 319, 2424-33 (2013)
  • Poppe H, Poppe LM, Bühler C, Machann W, Solymosi L, Dlaske H, Sommer C, Hamm H. Painful cyanotic discoloration of the distal phalanges IV and V of the left hand in a 53-year-old female smoker. J Dtsch Dermatol Ges 11, 887-91 (2013)
  • Klotz D, Kneitz H, Wirbelauer J. Primäre kutane Aspergillose bei einem extrem unreifen Frühgeborenen. Hautarzt 64, 664-5 (2013)
  • Houben R, Dreher C, Angermeyer S, Borst A, Utikal J, Haferkamp S, Peitsch WK, Schrama D, Hesbacher S. Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens. J Invest Dermatol 133, 2453-60 (2013)
  • Reich-Schupke S, Alm J, Altmeyer P, Bachter D, Bayerl C, Beissert S, Bieber t, Böhmer J, Dill D, Dippel E, Dücker P, Effendy I, El Gammal S, Elsner P, Enk A, Feldmann-Böddeker I, Frank H, Gehring W, Gieler U, Goebeler M, Görge T, Gollnick H, Grabbe S, Gross G, Gudat W, Happ A, Herbst R, Hermes B, Hoff NP, John SM, Jungelhülsing M, Jünger M, Kaatz M, Kapp A, Kaufmann R, Klode J, Knaber K, König A, Krieg T, Kohl P, Kowalzick L, Lehmann P, Löffler H, Maschke J, Marsch W, Mechtel D, Mohr P, Moll I, Müller M, Nashan D, Ockenfels HM, Peter RU, Pillekamp H, Rompel R, Ruzicka T, Salfeld K, Sander C, Schaller J, Scharffetter-Kochanek K, Schuler G, Schulze HJ, Schwarz T, Splieth B, Stege H, Stolz W, Strölin A, Tran H, Tronnier M, Ulrich J, Vogt T, Wagner G, Welzel J, Willgeroth T, Wollina U, Zillikens D, Zouboulis CC, Zuberbier T, Zutt M, Stücker M. Phlebologie an deutschen Hautkliniken (Eine Bestandsaufnahme im Auftrag der Deutschen Gesellschaft für Phlebologie). Hautarzt 64, 685-94 (2013)
  • Angermeyer S, Hesbacher S, Becker JC, Schrama D, Houben R. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen. J Invest Dermatol 133, 2059-64 (2013)
  • Wobser M, Goebeler M, Hamm H: Extensive red and blue patches in a young girl. Klin Pädiatr 225, 46-7 (2013)
  • Schaarschmidt ML, Umar N, Schmieder A, Terris DD, Goebeler M, Goerdt S, Peitsch WK. Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol 27, 187-98 (2013)
  • Anders D, Trautmann A. Allergic anaphylaxis due to subcutaneously injected heparin. Allergy Asthma Clin Immunol 9, e1-e4, (2013)
  • Buder K, Wendel AM, Cerroni L, Goebeler M, Kerstan A. A case of lymphomatoid papulosis limited to Becker's melanosis. Dermatology 226, 124-7 (2013)
  • Griewank KG, Ugurel S, Schadendorf D, Paschen A. New developments in biomarkers for melanoma. Curr Opin Oncol 25, 145-51 (2013)
  • Hohenauer T, Berking C, Schmidt A, Haferkamp S, Senft D, Kammerbauer C, Fraschka S, Graf SA, Irmler M, Beckers J, Flaig M, Aigner A, Höbel S, Hoffmann F, Hermeking H, Rothenfusser S, Endres S, Ruzicka T, Besch R. The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival. EMBO Mol Med 5, 919-34 (2013)
  • Chmara M, Wernstedt A, Wasag B, Peeters H, Renard M, Beert E, Brems H, Giner T, Bieber I, Hamm H, Sciot R, Wimmer K, Legius E. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency. Genes Chromosomes Cancer 52, 656-664 (2013)
  • Hildebrand DG, Lehle S, Borst A, Haferkamp S, Essmann F, Schulze-Osthoff K. α-Fucosidase as a novel convenient biomarker for cellular senescence. Cell Cycle 12, 1922-27 (2013)
  • Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 68, 702-12 (2013)
  • Poppe H, Kolb-Mäurer A, Wobser M, Trautmann A. Pitfall scarring alopecia: Favus closely mimicking lichen planus. Mycoses 56, 382-4 (2013)
  • Rauert-Wunderlich H, Siegmund D, Maier E, Giner T, Bargou RC, Wajant H, Stühmer T. The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors. PLoS ONE 8, e59292 (2013)
  • Kolb-Mäurer A, Hamm H, Kneitz H, Mäurer M. Makroglossie bei einem 53-jährigen Patienten mit Muskelbeschwerden. Hautarzt 64, 295-7 (2013)
  • Elias J, Heuschmann PU, Schmitt C, Eckhardt F, Boehm H, Maier S, Kolb-Mäurer A, Riedmiller H,Müllges W, Weisser C, Wunder C, Frosch M, Vogel U. Prevalence dependent calibration of a predictive model for nasal carriage of methicillin-resistant Staphylococcus aureus. BMC Infect Dis 13, 111 (2013)
  • Haferkamp S, Borst A, Adam C, Becker TM, Motschenbacher S, Windhövel S, Hufnagel AL, Houben R, Meierjohann S. Vemurafenib induces senescence features in melanoma cells. J Invest Dermatol 133, 1601-9 (2013)
  • Weishaupt J, Schön MP, Bröcker EB, Kerstan A. Multiple large flaccid purulent blisters in a patient with metastatic breast cancer. J Dtsch Dermatol Ges 11, 267-9 (2013)
  • Sbiera S, Kroiss M, Thamm T, Beyer M, Majidi F, Kuehner D, Wobser M, Becker JC, Adam P, Ronchi C, Allolio B, Fassnacht M. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential. Horm Metab Res 45, 137-46 (2013)
  • Poppe H, Poppe LM, Bröcker EB, Trautmann A. Do-it-yourself cement work: the main cause of severe irritant contact dermatitis requiring hospitalization. Contact Dermatitis 68, 111-5 (2013)
  • Poppe LM, Bröcker EB, Trautmann A. The one-nail brown band: Macro- and micro-morphology. Acta Derm Venereol 93, 479-80 (2013)
  • Lang SC, Glas S, Scheich M, Hamm H, Kerstan A, Bröcker EB. Primary diagnosis of hyalinosis cutis et mucosae in a 56-year-old man with persistent hoarseness and dysphonia. Eur J Dermatol 23, 272-3 (2013)
  • Schrama D, Hesbacher S, Becker JC, Houben R. Survivin downregulation is not required for T antigen knockdown mediated cell growth inhibition in MCV infected Merkel cell carcinoma cells. Int J Cancer 132, 2980-2 (2013)
  • Hamm H. Erworbene Alopezien im Kindesalter. Hautarzt 64, 371-381 (2013)
  • Stoevesandt J, Hain J, Trautmann A. Reply to: Alvarez-Twose I, Bonadonna P, Matito A, Zanotti R, Gonzáles-de-Olano D, Sánchez-Muñoz L, et al. Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis. J Allergy Clin Immunol 131, 615-6 (2013)
  • Ugurel S, Paschen A, Becker JC. Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent. J Invest Dermatol. 133, 289-92 (2013)
  • Pedersen IH, Willerslev-Olsen A, Vetter-Kauczok C, Krejsgaard T, Lauenborg B, Kopp KL, Geisler C, Bonefeld CM, Zhang Q, Wasik MA, Dabelsteen S, Woetmann A, Becker JC, Odum N. Vascular endothelial growth factor receptor-3 expression in mycosis fungoides. Leuk Lymphoma 54, 819-26 (2013)

Publikationen 2012

  • Poppe H, Kneitz H, Bröcker EB, Hamm H. In situ melanoma and palmar spiny hyperkeratoses: coincidence or paraneoplasia? Eur J Dermatol 22, 281-2 (2012)
  • Felcht M, Heck M, Weiss C, Becker JC, Dippel E, Müller CS, Nashan D Sachse MM, Nicolay JP, Booken N, Goerdt S, Klemke CD. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells. Br J Dermatol 167, 348-58 (2012)
  • Motschenbacher S, Buder K, Goebeler M, Kerstan A. Combined oral alitretinoin and narrowband UVB treatment of cutaneous T cell lymphoma: favourable response after multiple ineffective systemic therapies. Eur J Dermatol 22, 803-4 (2012)
  • Schmieder A, Schaarschmidt ML, Umar N, Terris DD, Goebeler M, Goerdt S, Peitsch WK: Comorbidities significantly impact patients’ preferences for psoriasis treatments.  J Am Acad Dermatol 67, 363-372 (2012)
  • Forstbauer LM, Brockschmidt FF, Moskvina V, Herold C, Redler S, Herzog A, Hillmer AM, Meesters C, Heilmann S, Albert F, Alblas M, Hanneken S, Eigelshoven S, Giehl KA, Jagielska D, Blume-Peytavi U, Bartels NG, Kuhn J, Hennies HC, Goebeler M, Jung A, Peitsch WK, Kortüm AK, Moll I, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Kirov G, Becker T, Nöthen MM, Betz RC. Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata.  Eur J Hum Genet 20, 326-32 (2012)
  • van Beek N, Knuth-Rehr D, Altmeyer P, Assaf C, Babilas P, Bayerl C, Benoit S, Dippel E, Effendy I, Eming R, Fischer M, Glaenz T, Gläser R, Goebeler M, Gollnick H, Götze S, Gross G, Hadaschik E, Herbst R, Hermes B, Homey B, Hunzelmann N, Jünger M, Kapp A, Kern JS, Körber A, Luger T, Mechtel D, Megahed M, Moll I, Peters KP, Pfeiffer C, Ring J, Röcken M, Sárdy M, Seitz CS, Stadler R, Steinbrink K, Sticherling M, Szeimies RM, Tronnier M, Ulrich J, Vogt T, Wagner N, Welzel J, Wenzel J, Wozel G, Zouboulis CC, Zillikens D, Schmidt E. Diagnostics of autoimmune bullous diseases in German dermatology departments. J Dtsch. Dermatol. Ges 10, 492-99 (2012)
  • Vlahova L, Doerflinger Y, Houben R, Brandner JM, Becker JC, Schrama D, C. Weiss C, Goebeler M, Helmbold P, Goerdt S, Peitsch WK. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival. Brit J Dermatol 166, 1043-52 (2012)
  • Raghavan B, Martin SF, Esser PR, Goebeler M, Schmidt M. Metal allergens nickel and cobalt facilitate TLR4 homodimerization independent of MD2. EMBO Reports 13, 1109-1115 (2012)
  • Alb M, Sie C, Adam C, Chen S, Becker JC, Schrama D. Cellular and cytokine dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma. Cancer Immunol Immunother 61, 2239-49 (2012)
  • Hosp C, Naumann MK, Hamm H. Botulinumtoxin bei fokaler Hyperhidrose. Ein aktueller Überblick. Hautarzt 63, 469-76 (2012)
  • Kerstan A, Beyersdorf N, Stoevesandt J, Trautmann A. Wasp venom immunotherapy expands a subpopulation of CD4(+)CD25+ forkhead box protein 3-positive regulatory T cells expressing the T-cell receptor Vβ2 and Vβ5.1 chains. J Allergy Clin Immunol 130, 994-6 e3 (2012)
  • Tran SL, Haferkamp S, Scurr LL, Gowrishankar K, Becker TM, Desilva C, Thompson JF, Scolyer RA, Kefford RF, Rizos H. Absence of distinguishing senescence traits in human melanocytic nevi. J Invest Dermatol 132, 2226-34 (2012)
  • Becker JC, Andersen MH, Hofmeister-Müller V, Wobser M, Frey L, Sandig C, Walter S, Singh-Jasuja H, Kämpgen E, Opitz A, Zapatka M, Bröcker EB, thor Straten P, Schrama D, Ugurel S. Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma. Cancer Immunol Immunother 61, 2091-103 (2012)
  • Heise R, Vetter-Kauczok CS, Skazik C, Czaja KM Marquardt Y, Lue HQ, Merk HF, Bernhagen J, Baron JM. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer. Photochem Photobiol 88, 1157-64 (2012)
  • Weber R, Trautmann A, Randerath W, Heppt W, Hosemann W. ASS-Toleranzinduktion: Therapieoption bei Patienten mit Analgetika-induzierter Erkrankung der Atemwege. HNO 60, 369-83 (2012)
  • Weise G, Hupp M, Kerstan A, Buttmann M. Lobular panniculitis and lipoatrophy of the thighs with Interferon-ß1a for intramuscular injection in a patient with multiple sclerosis. J Clin Neurosci 19, 1312-3 (2012)
  • Poppe LM, Anders D, Kneitz H, Bröcker EB, Benoit S. Flagellate dermatitis caused by shiitake mushrooms. An Bras Dermatol 87, 463-5 (2012)
  • Müller PA, Bröcker EB, Klinker E, Stoevesandt J, Benoit S. Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption. Dermatology 224, 224-7 (2012)
  • Lang I, Fick A, Schäfer V, Giner T, Siegmund D, Wajant H. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts. J Biol Chem 287, 24026-42 (2012)
  • Stoevesandt J, Hain J, Kerstan A, Trautmann A. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of  urticaria/angioedema. J Allergy Clin Immunol 130, 698-704 (2012)
  • Willmes C, Adam C, Alb M, Völkert L, Houben R, Becker JC, Schrama D. Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens. Cancer Res 72, 2120-8 (2012)
  • Hafner C, Houben R, Baeurle A, Ritter C, Schrama D, Landthaler M, Becker JC. Activation of the PI3K/AKT pathway in Merkel cell carcinoma. PLoS One 7, e31255 (2012)
  • Bergstraesser C, Hoeger S, Song H, Ermantraut L, Hottenrot M, Czymai T, Schmidt M, Goebeler M, Ponelies N, Stich C, Loesel R, Molema G, Seelen M, van Son W, Yard BA, Rafat N. Inhibition of VCAM-1 expression in endothelial cells by CORM-3: the role of the ubiquitin-proteasome system, p38, and mitochondrial respiration. Free Radic Biol Med 52, 794-802 (2012)
  • Trcka J, Schäd SG, Scheurer S, Conti A, Vieths S, Gross G, Trautmann A. Rice-induced anaphylaxis: IgE-mediated allergy against a 56-kDa glycoprotein. Int Arch Allergy Immunol 158, 9-17 (2012)
  • Bauer B, Majic M, Rauthe S, Bröcker EB, Kerstan A. Persistierende Schwellung nach Spülung eines Abszesses mit Octenisept®. Unfallchirurg 115, 1116-9 (2012)
  • Müller PA, Amann K, Bröcker EB, Trautmann A. Makulopapulöses Exanthem mit akuter Niereninsuffizienz. Arzneimittelinduziertes Hypersensitivitätssyndrom. Hautarzt 63, 223-5 (2012)
  • Anders D, Kneitz H, Kunstmann E, Bröcker EB, Benoit S. Muir-Torre-Syndrom. Eine interdisziplinäre Herausforderung. Hautarzt 63, 226-9 (2012)
  • Leiter U, Buettner PG, Eigentler TK, Bröcker EB, Voit C, Gollnick H, Marsch W, Wollina U, Meier F, Garbe C. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. J Am Acad Dermatol 66, 37-45 (2012)
  • Houben R, Adam C, Baeurle A, Hesbacher S, Grimm J, Angermeyer S, Henzel K, Hauser S, Elling R, Bröcker EB, Gaubatz S, Becker JC, Schrama D. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int J Cancer 130, 847-56 (2012)
  • Meyer KM, Klink T, Ugurel S, Bröcker EB. Regression of paclitaxel-induced maculopathy with oral acetazolamide. Graefes Arch Clin Exp Ophthalmol 250, 463-64 (2012)
  • Houben R, Grimm J, Willmes C, Weinkam R, Becker JC, Schrama D. Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis. J Invest Dermatol 132, 254-56 (2012)
  • Schrama D, Buck CB, Houben R, Becker J. No evidence for association of  HPyV6 or HPyV7 with different skin cancers. J Invest Dermatol 132, 239-41 (2012)
  • Stoevesandt J, Borozdin W, Girschick G, Hamm H, Höcht B, Kohlhase J, Volz A, Wiewrodt B, Wirbelauer J. Lethal junctional epidermolysis bullosa with pyloric atresia due to compound heterozygosity for two novel mutations in the integrin β4 gene. Klin Padiatr 224, 8-11 (2012)
  • van der Velden JJ, Jonkman MF, McLean WH, Hamm H, Steijlen PM, van Steensel MA, van Geel M. A recurrent mutation in the TGM5 gene in European patients with acral peeling skin syndrome. J Dermatol Sci 65, 74-6 (2012)
  • Kerstan A, Simon HU, Yousefi S, Leverkus M. Extensive accumulation of eosinophil extracellular traps in bullous delayed-pressure urticaria: a pathophysiological link? Br J Dermatol 166, 1151-2 (2012)
  • Stoevesandt J, Grundmeier N, Trautmann A. Gastroesophageal hymenoptera stings add to causes of idiopathic anaphylaxis. Ann Allergy Asthma Immunol 108, 125-6 (2012)
  • Hamm H, Höger P. Neues aus der Pädiatrischen Dermatologie. Hautarzt 63, 80-81 (2012)
  • Bauer B, Hamm H. Anuläre purpurische Erytheme an den Beinen. J Dtsch Dermatol Ges. 10, 199-201 (2012)
  • Stoevesandt J, Carlé L, Leverkus M, Hamm H. Control of large institutional scabies outbreaks. J Dtsch Dermatol Ges 10, 637-47 (2012)
  • Kneitz H, Hünermund A, Bröcker EB. Extramammary Paget disease involving one axilla. J Dtsch Dermatol Ges 10, 765-6 (2012)
  • Alexander S, Friedl P. Cancer invasion and resistance: interconnected processes of disease progression and therapy failure. Trends Mol Med 18, 13-26 (2012)
  • Bakker GJ, Andresen V, Hoffman RM, Friedl P. Fluorescence lifetime microscopy of tumor cell invasion, drug delivery, and cytotoxicity. Methods Enzymol 504, 109-25 (2012)

Publikationen 2011

  • Schmidt M, Goebeler M. Neues zur Pathophysiologie des allergischen Kontaktekzems auf Nickel. Allergo J 20, 74-80 (2011)    
  • Martin SF, Esser PR, Weber FC, Jakob T, Freudenberg MA, Goebeler M: Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66, 1152-63 (2011)
  • Schmidt M, Goebeler M. Nickel allergies: Paying the Toll for innate immunity. J Mol Med 89, 961-70 (2011)
  • Warnecke C, Manousaridis I, Herr R, Terris DD, Goebeler M, Goerdt S, Peitsch WK: Cardiovascular and metabolic risk profile in German patients with moderate and severe psoriasis: a case control study.  Eur J Dermatol 21, 761-70 (2011)
  • Schaarschmidt ML, Schmieder A, Umar N, Terris D, Goebeler M, Goerdt S, Peitsch WK: Patient preferences for psoriasis treatment. Process characteristics can outweigh outcome attributes. Arch Dermatol 147, 1285-94 (2011)
  • Schmidt M, Martin S, Freudenberg M, Goebeler M. Animal models for nickel allergy (letter). Nature Nanotechnol 6, 533 (2011)
  • Seitz CS, Bröcker EB, Trautmann A: Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing. Allergol Immunopathol (Madr.) 39, 193-9 (2011)
  • Felcht M, Faulhaber J, Schmieder A, Koenen W, Goerdt S, Goebeler M: Asymptomatischer Knoten am Daumen einer älteren Frau: Gichttophus. Hautarzt 62, 224-228 (2011)
  • Wobser M, Gaigl Z, Traumann A. The concept of "compartment allergy": prilocaine injected into different skin layers. Allergy Asthma Clin Immunol 7, 7 (2011)
  • Claudius K, Ginzkey C, Gattenlöhner S, Müller J, Demmer P, Bröcker EB. A red cheek as first clinical sign of a sebaceous lymphadenocarcinoma of the parotid gland with lymphangiosis carcinomatosa and lymph node metastases. Am J Dermatopathol 33, e50-3 (2011)
  • Egberts F, Gutzmer R, Ugurel S, Becker JC, Trefzer U, Degen A, Schenck F, Frey L, Wilhelm T, Hassel JC, Schadendorf D, Livingstone E, Mauch C, Garbe C, Berking C, Rass K, Mohr P, Kaehler KC, Weichenthal M, Hauschild A. Sorafenib and pegylated Interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial. Ann Oncol 2011, 22, 1667-74 (2011)
  • Kerstan A, Bröcker EB, Trautmann A. Decisive role of tumor necrosis factor-α for spongiosis formation in acute eczematous dermatitis. Arch Dermatol Res 303, 651-8 (2011)
  • Weyandt GH, Tollmann F, Kristen P, Weissbrich B. Low risk of contamination with human papilloma virus during treatment of condylomata acuminata with multilayer argon plasma coagulation and CO₂ laser ablation. Arch Dermatol Res 303, 141-4 (2011)
  • Häusler SF, Montalbán del Barrio I, Strohschein J, Anoop Chandran P, Engel JB, Hönig A, Ossadnik M, Horn E, Fischer B, Krockenberger M, Heuer S, Seida AA, Junker M, Kneitz H, Kloor D, Klotz KN Dietl J, Wischhusen J. Ectonucleotidases CD39 and CD 73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T-cell function and NK cell cytotoxicity. Cancer Immunol Immunother 60, 1405-18 (2011)
  • Williams T, Machann W, Kühler L, Hamm H, Müller-Höcker J, Zimmer M, Ertl G, Ritter O, Beer M, Schönberger J. Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratoderma. Clin Res Cardiol 100, 1087-93 (2011)
  • Florence ME, Massuda JY, Bröcker EB, Metze K, Cintra ML, Souza EM. Angiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers. Clinics 66, 465-8, (2011)
  • Stolze I, Hamm H, Weyandt GH. Segmental multilayered argon plasma coagulation: effective therapy option for perianal and scrotal Hailey-Hailey disease. Colorectal Dis 13, 802-4 (2011)
  • Grundmeier N, Hamm H, Weissbrich B, Lang SC, Bröcker EB, Kerstan A. High risk human papillomavirus infection in Bowen's disease of the nail unit: report of three cases and review of the literature. Dermatology 223, 293-300 (2011)
  • Hamm H, Höger PH. Skin tumors in childhood. Dtsch Arztebl Int. 108, 347-53 (2011)
  • Lill C, Schneider S, Item CB, Loewe R, Houben R, Halbauer D, Heiduschka G, Brunner M, Thurnher D. P53 mutation is a rare event in Merkel cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 268, 1639-46 (2011)
  • Livingstone E, Windemuth-Kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, Rotterdam S, Ugurel S, Schadendorf D. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer 47, 1977-89 (2011)
  • Stoevesandt J, Bröcker EB, Trautmann A. Folic acid allergy: no breakfast cereal hazard. Eur J Dermatol 21, 280-1 (2011)
  • Bergmann C, Wobser M, Morbach H, Falkenbach A, Wittenhagen D, Lassay L, Ott H, Zerres K, Girschick HJ, Hamm H. Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyerhidrosis caused by 15-PGHD/HPGD loss-of-function mutations. Exp. Dermatol 20, 531-3 (2011)
  • Storim J, Stoevesandt J, Anders D, Kneitz H, Bröcker EB, Trautmann A. Chelatbildner mit Thiolaktivität. Hautarzt 62, 215-18 (2011)
  • Weyandt GH. Neue operative Ansätze zur Sanierung anogenitaler HPV-Infektionen. Hautarzt 62, 28-33 (2011)
  • Lill C, Schneider S, Pammer J, Loewe R, Gedlicka W, Houben R, Heiduschka G, Brunner M, Thurnher D. Significant correlation of peptidyl-prolyl isomerase overexpression in Merkel cell carcinoma with overall survival patients. Head Neck 33, 1294-300 (2011)
  • Werling AM, Doerflinger Y, Brandner JM, Fuchs F, Becker JC, Schrama D, Kurzen H, Goerdt S, Peitsch WK. Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching. Histopathology 58, 286-303 (2011)
  • Kerstan A, Albert C, Klein D, Bröcker EB, Trautmann A. Wasp venom immunotherapy induces activation and homing of CD4(+)CD25(+) forkhead box protein 3-positive regulatory T cells controlling T(H)1 responses. J Allergy Clin Immunol 127, 495-501.e6 (2011)
  • Bröcker EB. Expert consensus: Histiopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice. J Dtsch Dermatol Ges 9, 659-60 (2011)
  • Held I, Rose C, Hamm H, Fölster-Holst R. The hair collar sign - a possible indication of cranial dysraphism. J Dtsch Dermatol Ges 9, 136-8 (2011)
  • Hünermund A, Wendel AM, Geissinger E, Bröcker EB, Stoevesandt J. Typically atypical: histiocytoid Sweet syndrome, associated with malignancy. J Dtsch Dermatol Ges 9, 666-9 (2011)
  • Kerstan A, Wendel AM, Kurzai O, Bröcker EB, Kolb-Mäurer A. Ulzerierende Knoten am rechten Arm nach Bisamrattenjagd. J Dtsch Dermatol Ges 9, 487-9 (2011)
  • Wieshuber C, Wendel AM, Trautmann A. Red plaques and difficult-to-treat asthma. J Dtsch Dermatol Ges 9, 312-3 (2011)
  • Wobser M, Kneitz H, Bröcker EB, Becker JC. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunotherapy - diagnostic and therapeutic challenges. J Dtsch Dermatol Ges 9, 204-11 (2011)
  • Schrama D, Scherer D, Schneider M, Zapatka M, Bröcker EB, Schadendorf D, Ugurel S, Kumar R, Becker JC. ERCC5 p.Asp1104His and ERCC2 p.Lys751GIn polymorphisms are independent prognostic factors for the clinical course of melanoma. J Invest Dermatol 131, 1280-90 (2011)
  • Schrama D, Peitsch WK, Zapatka M, Kneitz H, Houben R, Eib S, Haferkamp S, Moore PS, Shuda M, Thompson JF, Trefzer U, Pföhler C, Scolyer RA, Becker JC. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. J Invest Dermatol 131, 1631-8 (2011)
  • Mertes PM, Malinovsky JM, Jouffroy L, Working Group of the SFAR and SFA, Aberer W, Terreehorst I, Brockow K, Demoly P, ENDA, EAACI Interest Group on Drug Allergy, Bérard F, Bruyere M, Constant I, Debaene B, Drouet M, Karila C, Lavaud F, Lejus C, Longrois D, Lucas MM, Magnan A, Moneret-Vautrin DA, Mouton C, Plaud B, Ponvert C, Bavbek S, Bilo B, Bousquet PJ, Cernadas J, Garvey LH, Gooi H, Gomes E, Kowalski ML, Kvedariene V, Mosbech H, Pichler WJ, Romano A, Sargur R, Sanz M, Saretta F, Trautmann A. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 21, 442-53 (2011)
  • Seitz CS, Trautmann A. Cosmetic facial peel-induced contact anaphylaxis: chestnut allergy without latex-fruit syndrome. J Investig Allergol Clin Immunol 21, 494-5 (2011)
  • Houben R, Hesbacher S, Schmid CP, Kauczok CS, Flohr U, Haferkamp S, Müller CS, Schrama D, Wischhusen J, Becker JC. High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays. PLoS ONE 6, e22096 (2011)
  • Seitz CS, Bröcker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol 22, 405-10 (2011)
  • Poppe H, Kneitz H, Weyandt GH, Bröcker EB, Hamm H. Multiple translucent papules on the nose of a 5-year-old boy. Pediatr Dermatol 28, 53-4 (2011)
  • Wobser M, Bröcker EB, Hamm H. Asymptomatic purpuric lesions in segmental arrangements in a 10-year-old boy. Pediatr Dermatol 28, 727-8 (2011)
  • Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, Buslau M, Worm M, Blank N, Hein R, Müller-Ladner U, Kuhn A, Sunderkötter C, Juche A, Pfeiffer C, Fiehn C, Sticherling M, Lehmann P, Stadler R, Schulze-Lohoff E, Seitz C, Foeldvari I, Krieg T, Genth E, Hunzelmann N. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 13, R172 (2011)
  • Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009 (2011)
  • Patel PM, Suciu S, Mortier L, Kruit WH, Robert C, Schadendorf D, Trefzer U, Punt CJ, Dummer R, Davidson N, Becker J, Conry R, Thompson JA, Hwu WJ, Engelen K, Agarwala SS, Keiholz U, Eggermont AM, Spatz A, EORTC Melanoma Group. Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). Eur J Cancer 47, 1476-83 (2011)
  • Hauschild A, Egberts F, Garbe C, Bauer J, Grabbe S, Hamm H, Kerl H, Reusch M, Rompel R, Schlaeger M, expert group "Melanocytic nevi". Melanocytic nevi. J Dtsch Dermatol Ges 9, 723-34 (2011)
  • Frey LM, Houben R, Bröcker EB. Pigmentation, Melanocyte Colonization, and p53 Status in Basal Cell Carcinoma. J Skin Cancer 2011:349726 (2011)
  • Winter J, Kneitz H, Bröcker EB. Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology. J Skin Cancer 2011:241382 (2011)
  • Wobser M, Hamm H. Melanozytäre Nävi. Wissenswertes für den Pädiater. Monatsschr Kinderheilkd 159, 1077-84 (2011)
  • Weyandt GH. Notfallcheckliste: Akute Analfissur. MMW Fortschr Med 153, 39 (2011)